Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and "well state" bipolar patients

John I. Nurnberger, David C. Jimerson, Susan Simmons-Alling, Carol Tamminga, N. Suzan Nadi, Dawn Lawrence, Natraj Sitaram, J. Christian Gillin, Elliot S. Gershon

Research output: Contribution to journalArticle

51 Scopus citations

Abstract

Cholinergic supersensitivity has been postulated to be an etiologic factor in affective disorder. After several pilot dose-response studies, we administered 8 mg of the cholinergic agonist arecoline subcutaneously to eight pairs of normal volunteer identical twins and eight bipolar patients currently euthymic and unmedicated. During the hour following arecoline administration, the Profile of Mood States (POMS) showed an increase in total mood disturbance in both patient and control groups. Mean systolic blood pressure, pulse, plasma cortisol, prolactin, and growth hormone also increased. Anger and elation scores on the POMS showed significant concordance in identical twins, as did change in prolactin, implying that these are the components of drug response possibly influenced by genetic factors. None of these responses differentiated well state patients from controls. Thus, mood, behavioral, and neurochemical responses to arecoline, which appears to have nonspecific neurochemical effects at the dose employed, are not markers of vulnerability to affective illness.

Original languageEnglish (US)
Pages (from-to)191-200
Number of pages10
JournalPsychiatry Research
Volume9
Issue number3
DOIs
StatePublished - 1983

    Fingerprint

Keywords

  • Arecoline
  • behavioral effects
  • bipolar illness
  • genetic marker
  • neuroendocrine effects

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Psychology(all)

Cite this

Nurnberger, J. I., Jimerson, D. C., Simmons-Alling, S., Tamminga, C., Nadi, N. S., Lawrence, D., Sitaram, N., Gillin, J. C., & Gershon, E. S. (1983). Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and "well state" bipolar patients. Psychiatry Research, 9(3), 191-200. https://doi.org/10.1016/0165-1781(83)90043-4